COMPARATIVE EFFICACY AND SAFETY OF ROXITHROMYCIN AND CLARITHROMYCIN IN UPPER RESPIRATORY-TRACT INFECTIONS

被引：0
|
作者：
DECAMPORA, E
CAMAIONI, A
LEONARDI, M
FARDELLA, P
FIAONI, M
机构：
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1992年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Roxithromycin 300 mg once daily was compared with clarithromycin 250 mg b.i.d. in an open randomized trial in 200 patients with upper respiratory tract infection: sinusitis, pharyngotonsillitis, and otitis media. Average treatment duration was 9 days. Roxithromycin was more effective (p<0.01) particularly in otitis media and pharyngotonsillitis, and better tolerated (only 4% side effects, p<0.05).
引用
收藏
页码：S119 / S122
页数：4
相关论文
共 50 条
  • [1] Safety and efficacy of roxithromycin in patients with upper respiratory tract infections
    Barreto, DG
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 : 79 - 86
  • [2] SAFETY AND EFFICACY OF CLARITHROMYCIN IN THE TREATMENT OF ACUTE MILD TO MODERATE RESPIRATORY-TRACT INFECTIONS
    ONEILL, SJ
    MILLAR, ED
    COLES, SJ
    BACHAND, RT
    IRISH MEDICAL JOURNAL, 1991, 84 (01) : 33 - 35
  • [3] ROXITHROMYCIN AND LOWER RESPIRATORY-TRACT INFECTIONS
    SCOTT, WG
    COOPER, BC
    SCOTT, HM
    KARALUS, NC
    GARRETT, J
    LANG, SDR
    NEW ZEALAND MEDICAL JOURNAL, 1994, 107 (978) : 208 - 208
  • [4] EFFICACY AND SAFETY OF CLARITHROMYCIN COMPARED TO CEFIXIME AS OUTPATIENT TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS
    NEU, HC
    CHICK, TW
    CHEST, 1993, 104 (05) : 1393 - 1399
  • [5] MULTICENTER STUDY OF THE EFFICACY AND TOLERABILITY OF ROXITHROMYCIN IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS
    HIGUERARAMIREZ, F
    HIDALGO, H
    PRIETO, SC
    CARRASCO, AR
    PACHECO, MS
    SALITRERO, AV
    GRAJEDA, RR
    VITOLASS, FL
    MATOS, SEP
    DELGADO, SR
    GAYTAN, CM
    LOPEZ, GCC
    PEDRAZA, JAC
    HERNANDEZ, JLZ
    CHAPA, JSE
    LEAL, RP
    ESPARZA, JMG
    GUAJARDO, JLG
    CANTU, JDH
    URIBE, ADL
    CASTANON, LA
    GONZALEZ, GG
    TERRAZAS, RS
    GARCIA, MAG
    HERNANDEZ, PR
    DELAO, AV
    GAYLE, PHK
    GARZA, RA
    GOMEZ, FJP
    CANTU, PLL
    MAGANA, AL
    CADENA, AM
    HERNANDEZ, LR
    LINDSEY, RL
    GARCIA, SM
    TORRES, EC
    NONELL, ARZ
    MENDIOLA, AS
    RICO, FJM
    GONZALEZ, RGG
    AGUIRRE, JMG
    FRUTOS, JT
    MARTINEZ, JJR
    SERRANO, EGM
    MARSHAL, SP
    PADILLA, GRB
    CASTILLAS, JGP
    DIAZ, JEC
    CAMPOS, RG
    PALATTO, DC
    DRUG INVESTIGATION, 1991, 3 : 38 - 46
  • [6] MULTICENTER STUDY OF THE EFFICACY AND TOLERABILITY OF ROXITHROMYCIN IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS - DISCUSSION
    BERGOGNEBEREZIN, E
    GOMEZBARRETO, D
    RAMOSJIMENEZ, J
    RODRIGUEZNORIEGA, E
    DELACABADA, FJ
    ARREDONDOGARCIA, JL
    NILSEN, OG
    DRUG INVESTIGATION, 1991, 3 : 47 - 48
  • [7] UPPER RESPIRATORY-TRACT INFECTIONS
    RABINOWITZ, HK
    PRIMARY CARE, 1990, 17 (04): : 793 - 809
  • [8] INFECTIONS OF THE UPPER RESPIRATORY-TRACT
    LEVY, ML
    ERICSSON, CD
    PICKERING, LK
    MEDICAL CLINICS OF NORTH AMERICA, 1983, 67 (01) : 153 - 171
  • [9] ROXITHROMYCIN (RU 28965) IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS
    GRASSI, C
    BERTOLETTI, R
    DEROSE, V
    MANARA, G
    MANGIAROTTI, P
    CHEMIOTERAPIA, 1987, 6 (01): : 41 - 44
  • [10] COMPARISON OF AZITHROMYCIN VERSUS CLARITHROMYCIN IN THE TREATMENT OF PATIENTS WITH UPPER RESPIRATORY-TRACT INFECTIONS
    MULLER, O
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 137 - 146
12345